Iovance Biotherapeutics, Inc.
Clinical trials sponsored by Iovance Biotherapeutics, Inc., explained in plain language.
-
Immune cells from Patients' own tumors tested as new weapon against childhood cancers
Disease control OngoingThis early-stage study tests whether a treatment made from a patient's own tumor-fighting immune cells (TIL) is safe for children, teenagers, and young adults with solid tumors that have come back or stopped responding to standard treatments. About 40 participants will receive th…
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 10:59 UTC
-
Immune cell attack: new hope for tough melanoma?
Disease control OngoingThis study tests an experimental therapy called lifileucel, made from a patient's own immune cells (tumor-infiltrating lymphocytes), for advanced melanoma that has not responded to standard treatments. About 100 adults with unresectable or metastatic melanoma will receive this on…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC